AVADEL PHARMACEUTICALS PLC
(05337M104)
Fondsberichterstattung Bestände von AVADEL PHARMACEUTICALS PLC gemäß 13F Anmeldungen
| Firmenname | Gehaltene Aktien / Nennbetrag | Marktwert | Möglichkeit | Berichtszeitraum | Gültigkeitsdatum |
|---|---|---|---|---|---|
| Janus Capital Management LLC | 2,166,766 | $20,973k | Mar 31, 2017 | May 16, 2017 | |
| Broadfin Capital LLC | 3,102,673 | $8,967k | Jun 30, 2019 | Aug 14, 2019 | |
| Deerfield Management Company LP Series C | 2,722,241 | $7,867k | Jun 30, 2019 | Aug 14, 2019 | |
| Brown Capital Management LLC | 1,524,428 | $4,406k | Jun 30, 2019 | Aug 13, 2019 | |
| Tekla Capital Management LLC | 814,588 | $2,354k | Jun 30, 2019 | Aug 14, 2019 | |
| Renaissance Technologies LLC | 802,606 | $2,320k | Jun 30, 2019 | Aug 12, 2019 | |
| Brandes Investment Partners LP | 483,806 | $1,398k | Jun 30, 2019 | Aug 13, 2019 | |
| JW Asset Management LLC | 444,439 | $1,284k | Jun 30, 2019 | Aug 9, 2019 | |
| Acadian Asset Management LLC | 213,951 | $620k | Jun 30, 2019 | Aug 8, 2019 | |
| Baldwin Brothers Inc | 800 | $2k | Jun 30, 2019 | Jul 19, 2019 |